Literature DB >> 11405296

Degradation kinetics of oxycarbonyloxymethyl prodrugs of phosphonates in solution.

L C Yuan1, T C Dahl, R Oliyai.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11405296     DOI： 10.1023/a:1011044804823

Source DB:  PubMed          Journal:  Pharm Res        ISSN： 0724-8741            Impact factor:   4.200


× No keyword cloud information.
  4 in total

1.  Metabolism and pharmacokinetics of novel oral prodrugs of 9-[(R)-2-(phosphonomethoxy)propyl]adenine (PMPA) in dogs.

Authors:  J P Shaw; C M Sueoko; R Oliyai; W A Lee; M N Arimilli; C U Kim; K C Cundy
Journal:  Pharm Res       Date:  1997-12       Impact factor: 4.200

2.  Phosphoryloxymethyl carbamates and carbonates--novel water-soluble prodrugs for amines and hindered alcohols.

Authors:  M Safadi; R Oliyai; V J Stella
Journal:  Pharm Res       Date:  1993-09       Impact factor: 4.200

3.  (Acyloxy)alkyl carbamates as novel bioreversible prodrugs for amines: increased permeation through biological membranes.

Authors:  J Alexander; R Cargill; S R Michelson; H Schwam
Journal:  J Med Chem       Date:  1988-02       Impact factor: 7.446

4.  Pharmacokinetics, safety and bioavailability of HPMPC (cidofovir) in human immunodeficiency virus-infected subjects.

Authors:  M Wachsman; B G Petty; K C Cundy; H S Jaffe; P E Fisher; A Pastelak; P S Lietman
Journal:  Antiviral Res       Date:  1996-03       Impact factor: 5.970
  4 in total
  6 in total

Review 1.  Phosphonate prodrugs: an overview and recent advances.

Authors:  Kenneth M Heidel; Cynthia S Dowd
Journal:  Future Med Chem       Date:  2019-07       Impact factor: 3.808

2.  Intravaginal ring delivery of tenofovir disoproxil fumarate for prevention of HIV and herpes simplex virus infection.

Authors:  Pedro M M Mesquita; Rachna Rastogi; Theodore J Segarra; Ryan S Teller; N Merna Torres; Ashley M Huber; Patrick F Kiser; Betsy C Herold
Journal:  J Antimicrob Chemother       Date:  2012-03-30       Impact factor: 5.790

3.  Intravaginal ring eluting tenofovir disoproxil fumarate completely protects macaques from multiple vaginal simian-HIV challenges.

Authors:  James M Smith; Rachna Rastogi; Ryan S Teller; Priya Srinivasan; Pedro M M Mesquita; Umadevi Nagaraja; Janet M McNicholl; R Michael Hendry; Chuong T Dinh; Amy Martin; Betsy C Herold; Patrick F Kiser
Journal:  Proc Natl Acad Sci U S A       Date:  2013-09-16       Impact factor: 11.205

4.  Development of a Novel Formulation That Improves Preclinical Bioavailability of Tenofovir Disoproxil Fumarate.

Authors:  Melynda E Watkins; Steve Wring; Ryan Randolph; Seonghee Park; Kendall Powell; Lissa Lutz; Michelle Nowakowski; Ram Ramabhadran; Paul L Domanico
Journal:  J Pharm Sci       Date:  2016-12-14       Impact factor: 3.534

5.  Crystal Structure Analysis of the First Discovered Stability-Enhanced Solid State of Tenofovir Disoproxil Free Base Using Single Crystal X-ray Diffraction.

Authors:  Ji-Hun An; Alice Nguvoko Kiyonga; Woojin Yoon; Hyung Chul Ryu; Jae-Sun Kim; Chaeri Kang; Minho Park; Hoseop Yun; Kiwon Jung
Journal:  Molecules       Date:  2017-07-14       Impact factor: 4.411

6.  A comparative pharmacokinetic and tolerability analysis of the novel orotic acid salt form of tenofovir disoproxil and the fumaric acid salt form in healthy subjects.

Authors:  Yu Kyong Kim; Mun Ju Choi; Tae Young Oh; Kyung-Sang Yu; SeungHwan Lee
Journal:  Drug Des Devel Ther       Date:  2017-11-06       Impact factor: 4.162
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.